Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1978 1
1983 1
1984 3
1985 1
1986 3
1987 1
1988 1
1989 5
1990 9
1991 5
1992 15
1993 11
1994 10
1995 16
1996 15
1997 12
1998 7
1999 19
2000 19
2001 5
2002 17
2003 15
2004 14
2005 19
2006 37
2007 25
2008 31
2009 24
2010 41
2011 39
2012 25
2013 34
2014 31
2015 29
2016 40
2017 43
2018 36
2019 36
2020 38
2021 38
2022 33
2023 31
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

782 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Immunodeficiency 117"
Page 1
Ocular Syphilis: An Update.
Dutta Majumder P, Chen EJ, Shah J, Ching Wen Ho D, Biswas J, See Yin L, Gupta V, Pavesio C, Agrawal R. Dutta Majumder P, et al. Ocul Immunol Inflamm. 2019;27(1):117-125. doi: 10.1080/09273948.2017.1371765. Epub 2017 Oct 11. Ocul Immunol Inflamm. 2019. PMID: 29020491 Review.
This review aims to provide an update on the clinical presentation, diagnosis, and treatment of ocular syphilis. ...
This review aims to provide an update on the clinical presentation, diagnosis, and treatment of ocular syphilis. ...
Trimethoprim-associated hyponatremia.
Babayev R, Terner S, Chandra S, Radhakrishnan J, Mohan S. Babayev R, et al. Am J Kidney Dis. 2013 Dec;62(6):1188-92. doi: 10.1053/j.ajkd.2013.06.007. Epub 2013 Jul 26. Am J Kidney Dis. 2013. PMID: 23891358
A diagnosis of hyponatremia secondary to the diuretic effect of TMP subsequently was confirmed, with clinical hypovolemia and high renin, aldosterone, and urinary sodium levels. ...It should be considered for patients on high-dose TMP/SMX treatment and can be differentiate …
A diagnosis of hyponatremia secondary to the diuretic effect of TMP subsequently was confirmed, with clinical hypovolemia and high re …
Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial.
Andrews B, Semler MW, Muchemwa L, Kelly P, Lakhi S, Heimburger DC, Mabula C, Bwalya M, Bernard GR. Andrews B, et al. JAMA. 2017 Oct 3;318(13):1233-1240. doi: 10.1001/jama.2017.10913. JAMA. 2017. PMID: 28973227 Free PMC article. Clinical Trial.
MAIN OUTCOMES AND MEASURES: The primary outcome was in-hospital mortality and the secondary outcomes included the volume of intravenous fluid received and receipt of vasopressors. RESULTS: Among 212 patients randomized to receive either the sepsis protocol or usual care, 3 …
MAIN OUTCOMES AND MEASURES: The primary outcome was in-hospital mortality and the secondary outcomes included the volume of intravenous flui …
Central nervous system infection with Toxoplasma gondii.
Marra CM. Marra CM. Handb Clin Neurol. 2018;152:117-122. doi: 10.1016/B978-0-444-63849-6.00009-8. Handb Clin Neurol. 2018. PMID: 29604970 Review.
Central nervous system infection by Toxoplasma gondii, or Toxoplasma encephalitis, is the most common cause of brain mass lesions in human immunodeficiency virus (HIV)-infected patients. It usually presents as one or more brain abscesses, but it can also cause a diffuse en …
Central nervous system infection by Toxoplasma gondii, or Toxoplasma encephalitis, is the most common cause of brain mass lesions in human …
Immune deficiency in chronic rhinosinusitis: screening and treatment.
Chiarella SE, Grammer LC. Chiarella SE, et al. Expert Rev Clin Immunol. 2017 Feb;13(2):117-123. doi: 10.1080/1744666X.2016.1216790. Epub 2016 Aug 18. Expert Rev Clin Immunol. 2017. PMID: 27500811 Free PMC article. Review.
Areas covered: We performed a literature search in PubMed of the terms "immunodeficiency" and "sinusitis" or "rhinosinusitis" from 2006 through March 2016. ...Expert commentary: CRS is a common disease; in those patients with frequent exacerbations or who are refractory to …
Areas covered: We performed a literature search in PubMed of the terms "immunodeficiency" and "sinusitis" or "rhinosinusitis" from 20 …
A Review of HIV-Specific Patient-Reported Outcome Measures.
Engler K, Lessard D, Lebouché B. Engler K, et al. Patient. 2017 Apr;10(2):187-202. doi: 10.1007/s40271-016-0195-7. Patient. 2017. PMID: 27637488 Review.
The use of patient-reported outcome (PRO) measures to provide added feedback to health providers is receiving interest as a means of improving clinical care and patient outcomes, and contributing to more patient-centered care. In human immunodeficiency virus (HIV), …
The use of patient-reported outcome (PRO) measures to provide added feedback to health providers is receiving interest as a means of improvi …
A New Intravenous Immune Globulin: Novel or Not?
Bates BN, Olah ME. Bates BN, et al. Ann Pharmacother. 2021 Jan;55(1):117-122. doi: 10.1177/1060028020934722. Epub 2020 Jun 21. Ann Pharmacother. 2021. PMID: 32567360 Review.
OBJECTIVE: To assess the clinical use and determine the place in therapy for immune globulin intravenous (IV), human-slra, a recently approved IV immune globulin for the treatment of primary immune deficiency diseases (PIDD). ...STUDY SELECTION AND DATA EXTRACTION: …
OBJECTIVE: To assess the clinical use and determine the place in therapy for immune globulin intravenous (IV), human-slra, a recently …
Immune-based therapies for cytomegalovirus infection.
Razonable RR. Razonable RR. Immunotherapy. 2010 Jan;2(1):117-30. doi: 10.2217/imt.09.82. Immunotherapy. 2010. PMID: 20635892 Review.
Among the immune-based therapies that have been investigated in experimental and clinical settings are: passive immunotherapy with immunoglobulin; CMV vaccination; adoptive CMV-specific T-cell immunotherapy; and immune reconstitution strategies (HAART in AIDS patients, and …
Among the immune-based therapies that have been investigated in experimental and clinical settings are: passive immunotherapy with im …
Zidovudine: five years later.
McLeod GX, Hammer SM. McLeod GX, et al. Ann Intern Med. 1992 Sep 15;117(6):487-501. doi: 10.7326/0003-4819-117-6-487. Ann Intern Med. 1992. PMID: 1503352 Review.
Zidovudine, a nucleoside analog, was the first agent proved to be effective in the management of human immunodeficiency virus type 1 (HIV-1) infection. After demonstration of zidovudine's in-vitro activity against HIV-1 in 1985, the drug was rapidly evaluated in phase I an …
Zidovudine, a nucleoside analog, was the first agent proved to be effective in the management of human immunodeficiency virus type 1 …
782 results